WO2005034728A3 - Colon cleansing composition and method - Google Patents

Colon cleansing composition and method Download PDF

Info

Publication number
WO2005034728A3
WO2005034728A3 PCT/US2004/028215 US2004028215W WO2005034728A3 WO 2005034728 A3 WO2005034728 A3 WO 2005034728A3 US 2004028215 W US2004028215 W US 2004028215W WO 2005034728 A3 WO2005034728 A3 WO 2005034728A3
Authority
WO
WIPO (PCT)
Prior art keywords
cleansing composition
colon cleansing
colon
colon prior
composition
Prior art date
Application number
PCT/US2004/028215
Other languages
French (fr)
Other versions
WO2005034728A2 (en
Inventor
Semaan Abboud
Original Assignee
Semaan Abboud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Semaan Abboud filed Critical Semaan Abboud
Priority to CA002540147A priority Critical patent/CA2540147A1/en
Priority to EP04782649A priority patent/EP1701723A4/en
Publication of WO2005034728A2 publication Critical patent/WO2005034728A2/en
Publication of WO2005034728A3 publication Critical patent/WO2005034728A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Abstract

A composition and method for cleansing a colon prior to endoscopic procedure. More particularly, a combination of bisacodyl, metoclopramide, sodium, and/or a phosphorus containing composition administered in sequential doses for preparing a colon prior to colonoscopy.
PCT/US2004/028215 2003-09-23 2004-08-31 Colon cleansing composition and method WO2005034728A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002540147A CA2540147A1 (en) 2003-09-23 2004-08-31 Colon cleansing composition and method
EP04782649A EP1701723A4 (en) 2003-09-23 2004-08-31 Colon cleansing composition and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/668,071 US7049319B2 (en) 2003-09-23 2003-09-23 Colon cleansing composition and method
US10/668,071 2003-09-23

Publications (2)

Publication Number Publication Date
WO2005034728A2 WO2005034728A2 (en) 2005-04-21
WO2005034728A3 true WO2005034728A3 (en) 2005-10-27

Family

ID=34313425

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/028215 WO2005034728A2 (en) 2003-09-23 2004-08-31 Colon cleansing composition and method

Country Status (4)

Country Link
US (3) US7049319B2 (en)
EP (1) EP1701723A4 (en)
CA (1) CA2540147A1 (en)
WO (1) WO2005034728A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
DE102005041711A1 (en) * 2005-09-01 2007-03-08 Kappstein, Ines, Prof. Dr.med. Intestine-rinsing solution, useful to clean the intestine before intestine reflux and before operations, comprises a bouillon/broth and a salt concentrate for taste
CA2725125A1 (en) * 2008-05-23 2009-11-26 Kingston General Hospital Colon cleansing method and kit
US20100178360A1 (en) 2009-01-13 2010-07-15 Universite Libre De Bruxelles Nutritive composition
RU2651751C2 (en) 2011-01-28 2018-04-23 Уильям А. ШЕЙВЕР Method, composition and package for bowel cleansing

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39400A (en) * 1863-08-04 Improvement in lamp-burners
US22933A (en) * 1859-02-15 Stove
US85990A (en) * 1869-01-19 Levi branson
US20025A (en) * 1858-04-20 Churn
US45153A (en) * 1864-11-22 Improvement in oil-ejectors for oil-wells
US4403982A (en) * 1978-08-28 1983-09-13 Clayton Ralph S Colon cleansing system and technique
US4406655A (en) * 1978-08-28 1983-09-27 Clayton Ralph S Colon cleansing system and technique
IL86859A (en) * 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
US5219573A (en) * 1989-10-17 1993-06-15 Hershey Foods Corporation L-sugar laxatives
US5197950A (en) * 1990-07-20 1993-03-30 Clayton Ralph S Scheduled bowel management system
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6103268A (en) * 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
AUPN634595A0 (en) * 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
DK0858326T3 (en) * 1996-05-08 2003-07-07 Craig A Aronchick Non-aqueous colon laxatives
US6331116B1 (en) 1996-09-16 2001-12-18 The Research Foundation Of State University Of New York System and method for performing a three-dimensional virtual segmentation and examination
US5997906A (en) * 1996-11-13 1999-12-07 C.B. Fleet Company, Inc. Coated sodium phosphate bowel cleanser
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
KR100529512B1 (en) * 1997-04-18 2005-11-22 얀센 파마슈티카 엔.브이. Use of 5HT3 antagonists for promoting intestinal lavage
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
US6444198B1 (en) * 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
US20040092511A1 (en) * 1999-12-10 2004-05-13 Billstein Stephan Anthony Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
DE60225266T2 (en) 2001-05-18 2009-03-19 Sucampo Ag COMPOSITION WITH INDUCTIVE CATHARTIC EFFECT
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BROWN M.C. ET AL: "A randomized controlled evaluating the use of Ensure during preparation for colonoscopy", AMERICAN JOURNAL OF GASTEROENTEROLOGY, vol. 95, no. 9, September 2000 (2000-09-01), pages 2529, XP002425914 *
REYNOLDS J.E.F.: "Matindale: The Extra Pharmacopoeia pages 871-872, 892-895, 1764", vol. 13 ED, 1993, PHARMACEUTICAL PRESS, LONDON *
THOMSON P.D.R.: "Physicians desk reference", vol. 57 ED, 13 January 2003, MONTVALE, NJ, pages: 1339, XP008079448 *

Also Published As

Publication number Publication date
CA2540147A1 (en) 2005-04-21
US20080220087A1 (en) 2008-09-11
EP1701723A4 (en) 2007-05-09
US7049319B2 (en) 2006-05-23
EP1701723A2 (en) 2006-09-20
WO2005034728A2 (en) 2005-04-21
US7335664B2 (en) 2008-02-26
US20060073214A1 (en) 2006-04-06
US20050064043A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
TW200510375A (en) New compounds
ZA200606173B (en) Effervescent oral opiate dosage form
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
HUP0302792A3 (en) Cyclopropyl-fused pyrrolidine-based onhibitors of dipeptidyl peptidase iv and method for their preparation and pharmaceutical compositions containing the compounds
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
HUP0300163A3 (en) Clathrate complexes formed by hyaluronic acid derivates, process for their preparation and pharmaceutical compositions containing them and their use
HUP0302770A3 (en) Tripeptidyl peptidase inhibitors, process for their preparation and pharmaceutical compositions containing them
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
HUP0301685A3 (en) New aporphine esters and their use in therapy, process for their preparation and pharmaceutical compositions containing them
WO2002009679A3 (en) Use of 13-cis retinoic acid for the treatment of emphysema
HU0100489D0 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2005034728A3 (en) Colon cleansing composition and method
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
HUP0301185A3 (en) Compounds for treating impaired fundic relaxation, process for their preparation and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0301254A3 (en) Novel compounds, process fo their preparation and pharmaceutical compositions containing them
AU4445201A (en) Method for administering insulin to the buccal region
DE60300571D1 (en) [3,4-a: 3,4-c] Carbazole derivatives, process for their preparation and pharmaceutical compositions containing them
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
ID28784A (en) ENHANCED PROCESS FOR MAKING VERY PURE AROMATIC AROMATIC ACID
ZA200210361B (en) Method of administering bishosphonates.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2540147

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004782649

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004782649

Country of ref document: EP